Skip to content
MAPS· Kevin Cranford·AI score43

MAPS attends FDA public hearing on psychedelic drugs and plans written testimony on access and training

MAPS Attends Historic FDA Hearing on Psychedelics

AI summary

MAPS attended the FDA's September 14 public hearing on the potential future therapeutic use of psychedelic drugs and plans to submit written testimony on systems readiness.

Key facts

Organisation
MAPS
Jurisdiction
United States
Source
MAPS (maps.org)
Published
How this summary was made

The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: MAPS · maps.org

Connected to

Organisation
MAPS
Jurisdiction
United States

Other recent items on these topics